Sunday, February 9, 2014

Part 3: Medical Marijuana, Inc. (MJNA)




The third Marijuana penny stock is Medical Marijuana, Inc. (Computer Symbol: MJNA). Like all penny stocks, they sell on the OTC Market. MJNA produce marijuana products such as cannabis gum and hemp oils. The company is actively involved in the capitalization development and acquisition of hemp and medicinal hemp based consumer products as well as the supporting technologies. The stock sold on January 28, 2014 for 45 cents. It had a 52 week high of 50 cents and a low of 9 cents.      

MJNA’s  mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana Inc. is the first publicly held company vested in the medical marijuana and industrial hemp markets. The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries.

The corporation’s products range from patented and proprietary based cannabinoid products, to seed and stalk or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries.

The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 85 proprietary and patented cannabinoid; delivery methods that are more socially and medically acceptable than typical industry methods. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.

Medical Marijuana Inc.’s patented and proprietary technologies include the only pharmaceutical grade vertical Bio-Technology Company specializing in the standardization, production and extraction of phyto-cannabinoids. MJNA’s PhytoSPHERE Systems and their advanced plant growth technologies save significantly on resources necessary for production of medical grade cannabis. In addition to providing a medical grade end product, extracts and compounds, PhytoSPHERE Systems also includes pre-and-post production tracking, germplasm references, packaging and processing to ensure consistency and genetic purity.

Medical Marijuana Inc. continues to expand its ever growing portfolio of innovative businesses. Our newest partnership with Kannalife Sciences lends a perfect fit for the Medical Marijuana Inc., family of companies. In addition to Kannalife's years in the development of standardization in packaging cannabis based products the company was recently awarded an Exclusive License Agreement with National Institutes of Health – Office of Technology Transfer (“NIH-OTT”) for the Commercialization of U.S. Patent 6,630,507, “Cannabinoids as Antioxidants and Neuroprotectants” (the “’507 Patent”).

MJNA Logo

To Learn more visit www.KannaLife.com


Corporate Office
Medical Marijuana Inc.
4901 Morena Blvd. Suite 701
San Diego, CA 92117
Toll Free: (888) OTC-MJNA
Toll Free: (888) 682-6562
Facsimile: (888) 651-0349
.

No comments: